Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis

被引:38
作者
Loganathan, Aravinthan [1 ,2 ,3 ]
Kamalaraj, Narainraj [1 ,4 ]
El-Haddad, Carlos [1 ]
Pile, Kevin [1 ,3 ]
机构
[1] Campbelltown Hosp, Rheumatol Dept, Campbelltown, NSW, Australia
[2] Wollongong Hosp, Rheumatol, Campbelltown, NSW, Australia
[3] Univ Western Sydney, Campbelltown Campus, Campbelltown, NSW, Australia
[4] Western Sydney Univ, Sch Med, Campbelltown Campus, Campbelltown, NSW, Australia
关键词
psoriatic arthritis; rheumatoid arthritis; psoriasis; metabolic syndrome; cardiovascular risk; DISEASE-ACTIVITY; RISK; WOMEN; OBESITY; ASSOCIATION; IMPACT;
D O I
10.1111/1756-185X.14147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Psoriatic arthritis (PsA), rheumatoid arthritis (RA) and psoriasis (PsO) are associated with systemic inflammation and increased cardiovascular mortality and morbidity. Metabolic syndrome (MetS) is associated with systemic inflammation, and conditions associated with MetS, such as obesity, are associated with difficulty in attaining minimal disease activity (MDA) in individuals with inflammatory arthritis. This systematic review aims to determine whether there is an increased prevalence of MetS in PsA populations compared with PsO and RA populations. Methods A systematic review was conducted to assess the prevalence of MetS in PsA, PsO, and RA populations following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. The quality of the studies reviewed was assessed using the Joanna Briggs Institute Checklist for Prevalence Studies. Results The pooled prevalence of MetS in PsA populations was 0.46 +/- 0.06 (95% CI 0.40-0.51). In comparison, the prevalence of MetS in PsO and RA populations was 0.34 +/- 0.03 (95% CI 0.32-0.37) and 0.31 +/- 0.04 (95% CI 0.27-0.35), respectively. Patients with PsA were 1.62 +/- 0.036 (95% CI 1.50-1.74) and 1.66 +/- 0.038 (95% CI 1.54-1.79) times more likely to have MetS compared with PsO and RA populations. Conclusion The prevalence of MetS is significantly increased in PsA populations compared with PsO and RA populations. Further studies should be performed using a standardized definition of MetS in PsA, RA, and PsO populations to determine whether addressing the metabolic components in MetS offers any therapeutic benefits and in terms of attaining MDA and improving cardiovascular health.
引用
收藏
页码:1112 / 1120
页数:9
相关论文
共 46 条
[1]   Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases [J].
Abourazzak, Fatima Ezzahra ;
Mansouri, Samia ;
Najdi, Adil ;
Tahiri, Latifa ;
Nejjari, Chakib ;
Harzy, Taoufik .
CLINICAL RHEUMATOLOGY, 2014, 33 (11) :1549-1555
[2]   EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update [J].
Agca, R. ;
Heslinga, S. C. ;
Rollefstad, S. ;
Heslinga, M. ;
McInnes, B. ;
Peters, M. J. L. ;
Kvien, T. K. ;
Dougados, M. ;
Radner, H. ;
Atzeni, F. ;
Primdahl, J. ;
Sodergren, A. ;
Jonsson, S. Wallberg ;
van Rompay, J. ;
Zabalan, C. ;
Pedersen, T. R. ;
Jacobsson, L. ;
de Vlam, K. ;
Gonzalez-Gay, M. A. ;
Semb, A. G. ;
Kitas, G. D. ;
Smulders, Y. M. ;
Szekanecz, Z. ;
Sattar, N. ;
Symmons, D. P. M. ;
Nurmohamed, M. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :17-28
[3]   Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies [J].
Alinaghi, Farzad ;
Calov, Monika ;
Kristensen, Lars Erik ;
Gladman, Dafna D. ;
Coates, Laura C. ;
Jullien, Denis ;
Gottlieb, Alice B. ;
Gisondi, Paolo ;
Wu, Jashin J. ;
Thyssen, Jacob P. ;
Egeberg, Alexander .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) :251-+
[4]  
Bilecik NA, 2014, INT J CLIN EXP MED, V7, P2258
[6]   The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity [J].
Boehncke, Wolf-Henning ;
Boehncke, Sandra ;
Tobin, Anne-Marie ;
Kirby, Brian .
EXPERIMENTAL DERMATOLOGY, 2011, 20 (04) :303-307
[7]   Metabolic Syndrome and psoriatic arthritis: considerations for the clinician [J].
Caso, Francesco ;
Chimenti, Maria Sole ;
Navarini, Luca ;
Ruscitti, Piero ;
Peluso, Rosario ;
Girolimetto, Nicolo ;
Del Puente, Antonio ;
Giacomelli, Roberto ;
Scarpa, Raffaele ;
Costa, Luisa .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) :409-420
[8]   Meta-analysis methodology in the microbleeds field: The relevance of the clinical question and study quality in choosing the most appropriate model [J].
Charidimou, Andreas ;
Boulouis, Gregoire ;
Shams, Sara ;
Calvet, David ;
Shoamanesh, Ashkan .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 :348-349
[9]   Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies [J].
Choudhary, Saumya ;
Patel, Rachana ;
Pradhan, Dibyabhaba ;
Deval, Ravi ;
Singh, Harpreet ;
Thomas, George ;
Jain, Arun Kumar .
3 BIOTECH, 2020, 10 (03)
[10]   Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study [J].
Costa, Luisa ;
Caso, Francesco ;
Ramonda, Roberta ;
Del Puente, Antonio ;
Cantarini, Luca ;
Darda, Md Abud ;
Caso, Paolo ;
Lorenzin, Mariagrazia ;
Fiocco, Ugo ;
Punzi, Leonardo ;
Scarpa, Raffaele .
IMMUNOLOGIC RESEARCH, 2015, 61 (1-2) :147-153